203. 22q11.2 deletion syndrome Disease details / Clinical trials / Drug dev / DR info

Clinical trials : 5 /  Drugs : 7 - (DrugBank : 1) / Drug target genes : 14 - Drug target pathways : 23

22q11.2 deletion syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
IDDiseases (Sorted by drug repositionability)
20322q11.2 deletion syndrome
13Multiple sclerosis/Neuromyelitis optica
6Parkinson disease
17Multiple system atrophy
8Huntington disease
5Progressive supranuclear palsy
156Rett syndrome
97Ulcerative colitis
206Fragile X syndrome
3Spinal muscular atrophy
18Spinocerebellar degeneration
2Amyotrophic lateral sclerosis
140Dorabe syndrome
144Lennox-Gastaut syndrome
193Prader-Willi syndrome
215Tetralogy of Fallot
4Primary lateral sclerosis
205Fragile X syndrome related disease
127Frontotemporal lobar degeneration
78Hypopituitarism
21Mitochondrial disease
113Muscular dystrophy
70Spinal stenosis
85Idiopathic interstitial pneumonia
49Systemic lupus erythematosus
96Crohn disease
46Malignant rheumatoid arthritis